Trial Details
Not recruitingBasic Information
| Clinical ID | c3360 |
|---|---|
| Identifier | NCT00321412 |
| Trial Title | A Double-blind, Randomized, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Mild to Moderately Active Crohn's Patients With Fistulas |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease;Intestinal Fistula |
| Interventions | Drug: AST-120 |
Participant Information
| Sponsor | Ocera Therapeutics |
|---|---|
| City | - |
| Country/Region | United States;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |